Open Heart
Timing exercise to body clock improves cardiometabolic outcomes
Clinical takeaway: Matching exercise timing to chronotype produced larger improvements in systolic blood pressure, metabolic markers, and sleep quality.
Exercise is a cornerstone of cardiovascular prevention, but timing is rarely considered. This study examined whether aligning exercise with an individual’s biological clock improves outcomes.
In a 12-week randomized trial of 150 sedentary adults with cardiovascular risk factors, participants assigned to chronotype-matched exercise saw greater improvements across multiple measures than those exercising at mismatched times. Chronotype was determined using a validated questionnaire and confirmed with physiologic monitoring of circadian rhythm.
Chronotype-aligned exercise led to greater improvements across all cardiometabolic measures, including systolic and diastolic blood pressure, heart rate variability, aerobic capacity, LDL cholesterol, and fasting glucose.
The largest differences were seen in blood pressure and sleep. Systolic blood pressure fell by about 10.8 mm Hg with matched timing vs. 5.5 mm Hg with mismatched timing, with even greater reductions among those with hypertension at baseline. Sleep improved more with chronotype-matched exercise, reflecting better overall sleep quality and more restorative sleep compared with exercising at a mismatched time.
Benefits were seen in both “morning” and “evening” types, though effects were generally larger in morning-type participants. Both groups improved overall, reinforcing that exercise itself remains the primary driver of benefit, with timing adding an incremental effect.
“Integrating the principle of ‘chrono-exercise’—scheduling workouts according to an individual’s internal biological clock—may offer a novel and impactful approach to improving cardiovascular and metabolic health,” the authors conclude.
Source: Tariq A. Open Heart. 2026 Apr 14. Chronotype-aligned exercise timing in middle-aged adults at cardiometabolic risk: a randomised controlled trial